,,,hummm,,,,,it is very obvious that our present share price is a direct result of the latest PO at $4 plus the warrant!,,,it is not the science that holds us here,,its the strained financial situation that has followed us thru out this process,,,,,,,,,,it is unfortunate that we had to perform the latest financing so close to results of the BoM trial,,but then again,,remember these results were initially slated for,,Decemeber 2017, and it wont be our last financing!!!!,,,,,we shareholders have not been givien much of an opportuntity to reset our risk/reward position since the recent high!!!. However,,,in fairness to the Market,,,if we could have preempted the PO it can be assumed that we would still have volitility with shorts and any resets but there would be no anticipated trading ceiling in to curb buying enthusiasm!!!,,jmo